Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Nat Med. 2024 May;30(5):1500. doi: 10.1038/s41591-024-02910-1.
No abstract available

Publication types

  • Published Erratum